AGP Picks
View all

Electronics Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Electronics Press Releases.

Press releases published on November 6, 2026

Spyre Therapeutics Announces Grants of Inducement Awards
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2026
National Tirzepatide Online Telehealth Provider Ozari Health Launches Ozari Select Monthly Plan in All 50 States
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Nkarta to Host Webcast to Discuss Initial Clinical Data for NKX019 in Autoimmune Diseases at ACR Convergence 2026
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Doman Building Materials Group Ltd. Reports Third Quarter 2026 Financial Results
Trusted Long Island Public Adjuster, Republic Claims Associates, Launches Nor'easter Flood Claim Help Ahead of Late-November Federal Flood Insurance Deadline
Turkey Industrial Innovation: Strong Manufacturing Capacity and Custom Electrical Solutions by CHAC
138th Canton Fair: CHAC Low-Voltage Electrical Products and Custom Electrical Solutions
MNTN, INC. INVESTIGATION: MNTN Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights
Identity and Biometric Authentication Technologies Provider BIO-key Hosts Q3 Investor Call Friday, November 13 at 10am ET
מעבר לצמיחה המבוססת על היקף פעילות: אסטרטגיית הגלובליזציה 3.0 של צ'רי דוגלת בלוקליזציה מעמיקה ובפרקטיקות עסקיות אחראיות
DAVE, INC. INVESTIGATION: DAVE Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights
Wegweisende Therapie bei fortgeschrittener Herzinsuffizienz: Der wissenschaftliche Mitgründer von Repairon, Prof. Wolfram-Hubertus Zimmermann, erhält den „Galenus-von-Pergamon“-Preis 2026 für herausragende pharmakologische Grundlagenforschung

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Electronics Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.